These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 16858611

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets.
    Goldstein I, Wallet F, Nicolas-Robin A, Ferrari F, Marquette CH, Rouby JJ.
    Am J Respir Crit Care Med; 2002 Nov 15; 166(10):1375-81. PubMed ID: 12406838
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vivo efficacy of humanised intermittent versus continuous ceftazidime in combination with tobramycin in an experimental model of pseudomonal pneumonia.
    Croisier D, Martha B, Piroth L, Chavanet P.
    Int J Antimicrob Agents; 2008 Dec 15; 32(6):494-8. PubMed ID: 18804348
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacodynamic interest of ceftazidime continuous infusion vs intermittent bolus administration in patients with severe nosocomial pneumonia].
    Cousson J, Floch T, Vernet-Garnier V, Appriou M, Petit JS, Jovenin N, Lamiable D, Hoizey G.
    Pathol Biol (Paris); 2005 Dec 15; 53(8-9):546-50. PubMed ID: 16023303
    [Abstract] [Full Text] [Related]

  • 10. Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia.
    Elman M, Goldstein I, Marquette CH, Wallet F, Lenaour G, Rouby JJ, Experimental ICU Study Group.
    Anesthesiology; 2002 Jul 15; 97(1):199-206. PubMed ID: 12131123
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Pharmacodynamic optimization of ceftazidime against Pseudomonas aeruginosa: continuous infusion or intermittent administration?].
    Aguilar L, Giménez MJ, Martín JE, Prieto J.
    Rev Esp Quimioter; 2005 Mar 15; 18(1):21-5. PubMed ID: 15915228
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
    Lu Q, Yang J, Liu Z, Gutierrez C, Aymard G, Rouby JJ, Nebulized Antibiotics Study Group.
    Am J Respir Crit Care Med; 2011 Jul 01; 184(1):106-15. PubMed ID: 21474643
    [Abstract] [Full Text] [Related]

  • 18. Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections.
    Benko AS, Cappelletty DM, Kruse JA, Rybak MJ.
    Antimicrob Agents Chemother; 1996 Mar 01; 40(3):691-5. PubMed ID: 8851594
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure.
    Pea F, Viale P, Damiani D, Pavan F, Cristini F, Fanin R, Furlanut M.
    Antimicrob Agents Chemother; 2005 Aug 01; 49(8):3550-3. PubMed ID: 16048982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.